Citius Pharmaceuticals (CTXR) Live Share Price, Invest From India

Citius Pharmaceuticals Stock Performance

as on August 29, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.59
Day's Price Range
$0.63
$0.60
1.67%
Downside
5.00%
Upside
52 Week's Low
52 Week's High
$0.47
52-Week Price Range
$2.19
$0.60
21.88%
Downside
265.00%
Upside

Citius Pharmaceuticals share price movements today

Previous Close: $0.63
Open: $0.61
Volume: 922.2K
Market Cap: $15.8M
Day's Low - High: $0.59 - $0.63
52 Week Low - High: $0.47 - $2.19

Citius Pharmaceuticals Historical Returns

1 Month Return: + 26.31 %
3 Month Return: -3.66 %
1 Year Return: -55.07 %
3 Year Return: -97.31 %
5 Year Return: -98.85 %

Citius Pharmaceuticals Stock Fundamentals & Key Indicators

Check Citius Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$15.8M

EPS (TTM)

-2.03

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-53.9M

Revenue (TTM)

7.1M

Profit Margin

0.00%

Return On Equity TTM

-81.09%

Citius Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Citius Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Citius Pharmaceuticals	BUY	$15.8M	-98.85%	NA	0.00%	NA
Revolution Medicines	BUY	$46.2B	675.69%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$138.7B	173.88%	31.92	86.04%	NA
Moderna	BUY	$59.7B	-62.65%	-7.98	-12.57%	NA
Regeneron	BUY	$85.8B	21.77%	19.9	84.86%	0.44%

Stock Returns calculator for Citius Pharmaceuticals Stock including INR - Dollar returns

The Citius Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Citius Pharmaceuticals investment value today

Current value as on today

₹46,451

Returns

-₹53,549

(-53.55%)

Returns from Citius Pharmaceuticals Stock

-₹57,143 (-57.14%)

Dollar Impact

₹3,594 (+3.59%)

Analyst Recommendation on Citius Pharmaceuticals Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Citius Pharmaceuticals. Average target price of $4

Citius Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Citius Pharmaceuticals.

What analysts predicted

85%UPSIDE

Target Price

Current Price

$0.6

Analyzed by

1 Analysts

Target

$4.00

Citius Pharmaceuticals target price $4, a slight upside of 85% compared to current price of $0.6. According to 1 analysts rating.

Indian Investors' Interest in Citius Pharmaceuticals Stock

Search interest for Citius Pharmaceuticals Stock has increased by 250% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 1, 2026 to August 31, 2026

Change:250% versus previous 30 day period

Citius Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	0	0	-	-	-	3	1	1
Gross Profit	0	0	0	0	0	0	0	2	0	0
Operating Income	-10	-10	-11	-10	-11	-8	-8	-9	-32	-11
EBITDA	-10	-10	-10	-9	-11	-8	-8	-8	-30	-9
Interest Expense	-	-	-	-	-	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-8	-10	-10	-10	-11	-8	-8	-9	-28	-12
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-8	-10	-10	-9	-10	-8	-7	-8	-21	-8
Net Profit Margin	0.00%	0.00%	-6920.05%	-6264.67%	0.00%	0.00%	0.00%	-208.43%	-1273.39%	-593.31%

Citius Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-7	-9	-13	-15	-17	-23	-33	-36	-41	-38
EBITDA	-7	-9	-13	-15	-17	-22	-33	-36	-38	-38
Interest Expense	0	0	0	0	0	0	0	-	-	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-10	-12	-15	-17	-23	-33	-31	-38	-38
Income Tax Expense	0	0	1	0	0	0	0	0	0	1
Net Income	-8	-10	-12	-15	-17	-23	-33	-32	-39	-37
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Citius Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-10	-11	-10	-11	-9	-8	-9	-28	-8
Operating Cash Flow	-8	-5	-4	-4	-5	-11	-13	-1	-8
Investing Cash Flow	-	-5	-5	-	-	-5	-4	0	-2
Financing Cash Flow	13	-3	2	3	11	15	20	-1	23
Change in Cash	5	-14	-2	-1	6	-1	3	-3	12

Citius Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-10	-12	-15	-17	-23	-33	-32	-39	-39
Operating Cash Flow	-7	-11	-12	-16	-24	-28	-29	-28	-26
Investing Cash Flow	0	0	0	0	-40	-	-	-5	-5
Financing Cash Flow	10	17	11	22	120	0	13	9	33
Change in Cash	2	5	-1	5	56	-28	-15	-23	1

Mutual Funds that own Citius Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Citius Pharmaceuticals.

Funds	Holdings	Shares Held
TIAA-CREF Funds	1.765404%	484649
VANGUARD INDEX FUNDS	0.61101%	167738
Fidelity Concord Street Trust	0.479842%	131729
Northern Funds	0.241868%	66399
Victory Portfolios III	0.054912%	15075

Global Institutional Holdings in Citius Pharmaceuticals

Funds	Holdings
Vanguard	0.72%

Insights on Citius Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 527.5%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 18.3% return, outperforming this stock by 115.7%
NEGATIVE IMPACT
Price Dip
In the last 3 years, CTXR stock has moved down by -97.4%

About Citius Pharmaceuticals

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

Organisation	Citius Pharmaceuticals
Headquarters	11 Commerce Drive, Cranford, NJ, United States, 07016
Industry	Biotechnology
CEO	Mr. Leonard L. Mazur
E-voting on shares	Click here to vote

Key Management of Citius Pharmaceuticals

Name	Title
Mr. Leonard L. Mazur	Co-Founder, CEO, Chairman & Secretary
Mr. Jaime Bartushak	Chief Business Officer & CFO
Mr. Gary F. Talarico	Executive Vice President of Operations
Ms. Ilanit Allen	Vice President of Investor Relations & Corporate Communications
Mr. Dhananjay G. Wadekar	Senior Vice President of Business Strategy
Mr. Myron Z. Holubiak	Co-Founder & Executive Vice Chairman
Dr. Myron S. Czuczman M.D.	Executive VP & Chief Medical Officer
Dr. Alan Lader Ph.D.	Senior VP and Head of Clinical Operations & Quality Assurance
Mr. Kelly Creighton Ph.D.	Executive Vice President of Chemistry, Manufacturing & Controls
Mr. Nikolas Burlew	Executive Vice President of Quality Assurance

FAQs

What is Citius Pharmaceuticals share price today?

Citius Pharmaceuticals share price today is $0.60 as on August 29, 2026 at 8:46 am IST at the close of the market. Citius Pharmaceuticals share today touched a day high of $0.63 and a low of $0.59.

What is the 52 week high and 52 week low for Citius Pharmaceuticals share?

Citius Pharmaceuticals share touched a 52 week high of $2.19 on October 20, 2025 and a 52 week low of $0.47 on July 20, 2026. Citius Pharmaceuticals stock price today i.e. August 29, 2026 at 8:46 am IST is closed at $0.60,which is 72.60% down from its 52 week high and 28.01% up from its 52 week low.

What is Citius Pharmaceuticals's market capitalisation today?

Citius Pharmaceuticals market capitalisation is $0.00T as on August 29, 2026 at 8:46 am IST.

How to invest in Citius Pharmaceuticals Stock (CTXR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Citius Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Citius Pharmaceuticals Shares that will get you 2.5000 shares as per Citius Pharmaceuticals share price of $0.60 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Citius Pharmaceuticals Stock (CTXR) from India?

Indian investors can start investing in Citius Pharmaceuticals (CTXR) shares with as little as ₹95.38 or $1 (as of August 31, 2026 at 2:47 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Citius Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2026 at 2:47 am IST). Based on Citius Pharmaceuticals share’s latest price of $0.60 as on August 29, 2026 at 8:46 am IST, you will get 16.6667 shares of Citius Pharmaceuticals. Learn more about fractional shares .

What are the returns that Citius Pharmaceuticals has given to Indian investors in the last 5 years?

Citius Pharmaceuticals stock has given -98.85% share price returns and 30.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?